Therefore, current research aims to identify the influence of diabetes on lipid profile, serum PSA, and endocrine factors such as insulin, IGF-1, and testosterone in prostate cancer and its association with progression, risk, and aggressiveness of prostate cancer. This evidence concerns the gene IGF1 and prostate cancer.